Combination of ICSs and LABAs Should Be Used in the Management of Patients with COPD -- The Con Argument
The management of patients with symptomatic chronic obstructive pulmonary disease (COPD) has become more clear in the past several years. New medications have been developed and their efficacy has been evaluated using important outcomes in addition to forced expiratory volume in 1 s (FEV1), suc...
| 出版年: | Canadian Respiratory Journal |
|---|---|
| 第一著者: | |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Wiley
2004-01-01
|
| オンライン･アクセス: | http://dx.doi.org/10.1155/2004/284010 |